Last update 21 Nov 2024

[123I]MNI-168

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
Target
APP
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors), SPECT(Single-photon emission-computed tomography enhancers)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Alzheimer DiseaseDiagnostic agents
Originator Organization
Institute for Neurodegenerative DisordersInstitute for Neurodegenerative Disorders
Active Organization-
Inactive Organization
Institute for Neurodegenerative DisordersInstitute for Neurodegenerative Disorders
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with [123I]MNI-168
NCT00870519 / TerminatedPhase 1IIT
Evaluation of [123I] MNI-168 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
100 Clinical Results associated with [123I]MNI-168
Login to view more data
100 Translational Medicine associated with [123I]MNI-168
Login to view more data
100 Patents (Medical) associated with [123I]MNI-168
Login to view more data
100 Deals associated with [123I]MNI-168
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 1
US
-01 Jan 2009
Diagnostic agentsPhase 1-
Institute for Neurodegenerative DisordersInstitute for Neurodegenerative Disorders
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free